Digital health companies at Seed through Series B stage building platforms with mental health, behavioural health, or psychological wellbeing components. This includes mental health platforms, preventative health tools with behavioural features, neurodevelopmental platforms, and AI-enabled clinical tools.

Most clients engage through ongoing advisory retainers, which include quarterly strategic sessions and ad-hoc support for questions and document review. We also provide project work such as clinical safety assessments or evidence strategy development. We limit our client base to 2-3 companies to ensure depth of engagement.

Quarterly strategic planning sessions, ad-hoc access for questions and document review, and ongoing guidance on clinical positioning, evidence generation, regulatory pathways, and stakeholder preparation.

Strategic advisory retainers typically run for 6-12 months minimum. Specific projects (clinical safety assessments, evidence strategy, regulatory guidance) typically take 2-4 weeks depending on scope and complexity.

Yes, though our primary expertise is in UK regulatory pathways (MHRA, NICE, NHS adoption). We can provide clinical strategy and safety governance guidance to companies in other markets, particularly those planning UK expansion.

We combine clinical practice, regulatory knowledge, and strategic advisory experience.
This allows us to support decision-making beyond clinical validation alone.

Initial conversations are exploratory—to understand your challenges, stage, and whether there's potential fit. No obligation, no pressure. Contact us to schedule a brief call.

Engagements are tailored to company stage and needs. Most clients work with us through ongoing strategic advisory retainers, often combined with specific project work such as clinical safety assessments or evidence strategy.

Pricing is discussed once we understand your context and can recommend an appropriate engagement structure.

Initial exploratory conversations are complimentary.